Thank you, Madam Chair.
If I understood you correctly, there is going to be an investment in the pandemic budget. I think what you said earlier was that we don't know the details, but there's going to be a press release.
I know the minister is very interested in neurological research, so I want to bring to your attention new research. I would ask that the expert panel on MS do a comprehensive literature review on CCSVI, that it visit labs and operating theatres, that it go to the international conferences. I've been to four of them, and there has not been a government representative at any of them.
There is a new study, of which Canada is a part. It is a multi-centre study. It's the first one of its kind. There are 700 cases, and upwards of 86% of MS patients show evidence of CCSVI. In New York, Minister, 150 MS cases were looked at. They were assessed for quality of life, and the psychiatrist who did that study did not know that the patients had received liberation therapy. I'd be happy to provide all unpublished studies. I'd be happy to share them with you.
I'm really pleased to hear that we will have a registry for MS. I've been asking for this since the spring, and we're just thrilled that MS patients will be followed after having liberation therapy. I think the data is very important. I'd like to know the details. When is it going to start? Who's going to do it? What will the cost be?
I'm wondering why this wasn't possible in the spring but is somehow now possible.